While the world has made significant progress in providing improved healthcare, major gaps remain. Through our Global Public Health (GPH) strategy, we are driven to foster better health for more people in more places around the world.
Johnson & Johnson GPH is the first fully dedicated organization within a healthcare company focused on combining innovative R&D, novel access programs, country-based operations and advocacy.
We are committed to pioneering and sustainably delivering meaningful and transformational products that save lives, cure patients and prevent disease for those most in need. Upholding the rich heritage of Johnson & Johnson, we are taking on the toughest challenges, targeting transformational health outcomes for individuals and communities.
We focus our efforts on:
We deliver impact by:
While ending HIV and TB is an ambitious goal, I firmly believe that with today’s scientific advancements and growing collaboration among the global health community to leverage our combined resources and decades of experience in HIV and TB, it is an achievable one.